Stephanie Ascough

Dr. Stephanie Ascough is a Researcher in the Department of Infectious Disease at Imperial College London, affiliated with the Institute of Infection. She holds a PhD in immunology from Imperial College London, focusing on Anthrax and Plague vaccine design, specifically T cell epitope mapping. Her professional experience includes research on Filariasis and Onchocerciasis in The Gambia (funded by The Gates Foundation) and work with the Avian Viral Immunology Group at The Pirbright Institute, enhancing live recombinant poxvirus vaccines against H5N1.

Research Interests: Her current work centers on defining correlates of protection in respiratory viral infections (influenza, COVID-19, RSV) through assay development. This involves analyzing innate, humoral, and cell-mediated immunity using clinical trial samples to improve vaccine efficacy. Her expertise spans immunogenicity studies, microarray analysis, and experimental infection challenges.

Grants & Collaborations: Her research has been supported by The Gates Foundation. She collaborates closely with clinical teams on early-phase vaccine trials and infection challenge studies.

Labs & Teams: She manages laboratory aspects of clinical trials within the Department of Infectious Disease, contributing to both experimental and translational research.